MARKETS / NYSE / YCBD
NYSE · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · SMALL CAP

cbdMD, Inc. YCBD

10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$19.2M
▼ 1.5% vs FY2024
EPS · FY25
$-1.09
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-44.4%
Net margin · FY25
-10.6%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 19.2M
Revenue, FY2025 · full 10-year series below
Revenue Net income
0.020.040.060.0-0.02016201920222025
0.020.040.060.0-0.02016201920222025

The company lost 11 cents on every revenue dollar this year.

Per share
USD -1.09
Diluted EPS, FY2025
EPS
0.40.81.2-1.092016201920222025
0.40.81.2-1.092016201920222025

The company pays no cash dividend.

Profitability
-44.4%
Return on equity, FY2025
ROE
81624-44.4%2016201920222025
81624-44.4%2016201920222025
Operating margin-11.3%
Net margin-10.6%
Return on assets-19.4%

Each USD of equity lost 44 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
−14.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−18.5%
−14.5%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2025
0.000.012016201920222025
0.000.012016201920222025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.4M
total assets, end of FY2025
Total assetsUSD 10.4M
EquityUSD 7.2M
CashUSD 2.3M
Current ratio2.05×

Equity funds 69% of total assets.

History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.1
−0.0
0.0
−0.1
0.0
−0.0
−0.0
EPS, diluted $
−1.09
−14.29
−13.32
−55.80
−0.47
0.28
0.00
0.00
−0.38
−1.13
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
−11
3
−0
·
·
·
ROE %
−44.4
−67.3
−113.4
−104.2
−25.7
21.6
−199.0
0.7
−60.6
−1072.1
Shares out B
0.01
0.00
0.00
0.00
0.06
0.05
0.03
0.01
0.01
0.00

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
40 of 40
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed